Evidence map›Paper›PMID 39046503›Full record

ArticleAnalytical and bioanalytical chemistry2024

Rapid detection of ricin at trace levels in complex matrices by asialofetuin-coated beads and bottom-up proteomics using high-resolution mass spectrometry.

Paloma Piquet, Justyna Saadi, François Fenaille, Suzanne R Kalb, François Becher

Abstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paloma PiquetDépartement Médicaments Et Technologies Pour La Santé (DMTS), INRAE, CEA, Université Paris-Saclay, 91191, Gif-Sur-Yvette, France.
Justyna SaadiDépartement Médicaments Et Technologies Pour La Santé (DMTS), INRAE, CEA, Université Paris-Saclay, 91191, Gif-Sur-Yvette, France.
François FenailleDépartement Médicaments Et Technologies Pour La Santé (DMTS), INRAE, CEA, Université Paris-Saclay, 91191, Gif-Sur-Yvette, France.ORCID http://orcid.org/0000-0001-6787-4149
Suzanne R KalbDivision of Laboratory Sciences, Centers for Disease Control and Prevention, National Center for Environmental Health, Atlanta, GA, 30341, USA.ORCID http://orcid.org/0000-0002-8067-136X
François BecherDépartement Médicaments Et Technologies Pour La Santé (DMTS), INRAE, CEA, Université Paris-Saclay, 91191, Gif-Sur-Yvette, France. francois.becher@cea.fr.ORCID http://orcid.org/0000-0002-1075-9980

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ricin is a toxic protein regarded as a potential chemical weapon for bioterrorism or criminal use. In the event of a ricin incident, rapid analytical methods are essential for ricin confirmation in a diversity of matrices, from environmental to human or food samples. Mass spectrometry-based methods provide specific toxin identification but require prior enrichment by antibodies to reach trace-level detection in matrices. Here, we describe a novel assay using the glycoprotein asialofetuin as an alternative to antibodies for ricin enrichment, combined with the specific detection of signature peptides by high-resolution mass spectrometry. Additionally, optimizations made to the assay reduced the sample preparation time from 5 h to 80 min only. Method evaluation confirmed the detection of ricin at trace levels over a wide range of pH and in protein-rich samples, illustrating challenging matrices. This new method constitutes a relevant antibody-free solution for the fast and specific mass spectrometry detection of ricin in the situation of a suspected toxin incident, complementary to active ricin determination by adenine release assays.

Indexed as

Mass SpectrometryProteomicsRicinHumansLimit of DetectionRicinAsialofetuinEnrichmentHigh-resolution mass spectrometryRicinSample preparationToxin

Identifiers

PMID39046503
PMCPMC11377644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.